Literature DB >> 4966497

Blood supply and vascular pattern of induced primary hepatic carcinoma in rats. A microangiographic and histologic investigation.

L A Nilsson, L Zettergren.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4966497     DOI: 10.1111/j.1699-0463.1967.tb05156.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand        ISSN: 0365-5555


× No keyword cloud information.
  8 in total

1.  Intraarterial hepatic chemotherapy with fluorouracil, fluorodeoxyuridine, mitomycin C, cisplatin or methotrexate as single-agent anticancer drugs for a transplanted experimental liver tumor in rats.

Authors:  S Kurth; D Bulian; B Kreft; T Riemenschneider
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

2.  Treatment of primary and secondary liver cancer by hepatic artery ligation and infusion chemotherapy.

Authors:  J G Fortner; R J Mulcare; A Solis; R C Watson; R B Golbey
Journal:  Ann Surg       Date:  1973-08       Impact factor: 12.969

3.  Temporary liver dearterialization in patients with metastatic carcinoid disease.

Authors:  S Bengmark; M Ericsson; A Lunderquist; H Mårtensson; A Nobin; M Sako
Journal:  World J Surg       Date:  1982-01       Impact factor: 3.352

4.  [Regression and therapy-resistance of primary liver tumors and liver metastases after regional chemotherapy and local tumor ablation].

Authors:  H-P Fischer
Journal:  Pathologe       Date:  2005-05       Impact factor: 1.011

5.  Lipiodol retention and massive necrosis after lipiodol-chemoembolization of hepatocellular carcinoma: correlation between computed tomography and histopathology.

Authors:  T Imaeda; Y Yamawaki; M Seki; H Goto; G Iinuma; M Kanematsu; R Mochizuki; H Doi; S Saji; K Shimokawa
Journal:  Cardiovasc Intervent Radiol       Date:  1993 Jul-Aug       Impact factor: 2.740

6.  Arterial, portal or combined arterio-portal regional chemotherapy in experimental liver tumours?

Authors:  T Riemenschneider; C Ruf; H C Kratzsch; M Ziegler; G Späth
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

7.  Experimental studies on the treatment of nonresectable liver cancer.

Authors:  H Yukaya; N Nagasue; K Inokuchi
Journal:  Jpn J Surg       Date:  1981-01

8.  Intra-hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of tumors implanted in rat livers by inducing platinum-DNA adducts to form and massive apoptosis.

Authors:  Mitsuharu Hanada; Akemi Baba; Yasuyuki Tsutsumishita; Toshihiro Noguchi; Takashi Yamaoka; Nobuyoshi Chiba; Fumio Nishikaku
Journal:  Cancer Chemother Pharmacol       Date:  2008-12-24       Impact factor: 3.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.